Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent split-virion influenza vaccine in 3–8-year-old children
CTR20212386Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Oct 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of quadrivalent split-virion inactivated influenza vaccine in influenza, sponsored by Sinovac Biotech Ltd.. Started Oct 2021; status: completed.
02
Drugs
quadrivalent split-virion inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20212386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212386.